News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pharma R&D Cuts Impairing U.S. Competitive Standing



1/6/2014 8:20:27 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A recent article in the New England Journal of Medicine (NEJM) should send warning signals to all interested in the state of the biopharmaceutical R&D in the U.S. The article, “Asia’s Ascent – Global Trends in Biomedical R&D Expenditures”, analyzes global biomedical R&D spending for the period between 2007 and 2012. While the article focuses on the relative rise in spending by Japan, China and India, the eye-opening data for me are the numbers from the U.S. The authors point out that the U.S. share of this global spend has fallen from 51.2% in 2007 to 45.4% in 2012. Europe’s investment was essentially unchanged and Asia’s increased from 18.1% to 23.8%. Further digging into the numbers revealed the following.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Forbes


comments powered by Disqus
Forbes
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES